Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Orestes V Forlenza

Showing results (41-50 of 135) with videos related to

Pageof 14
Sort By:
Neuropsychiatric Disease and Treatment|July 18, 2014
Eye movement analysis and cognitive processing: detecting indicators of conversion to Alzheimer's diseaseMarta Lg Freitas Pereira, Marina von Zuben A Camargo, Ivan Aprahamian, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|July 31, 2009
Short cognitive performance test: diagnostic accuracy and education bias in older Brazilian adultsMariana K Flaks, Orestes V Forlenza, Fernanda S Pereira, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|April 14, 2012
A radioenzymatic assay to identify three groups of phospholipase A(2) in plateletsLeda L Talib, Breno S Diniz, Isis A Zainaghi, et al.
Current Alzheimer Research|February 20, 2016
Lithium Distinctly Modulates the Secretion of Pro- and Anti- Inflammatory Interleukins in Co-Cultures of Neurons and Glial Cells at Therapeutic and Sub-Therapeutic ConcentrationsVanessa J De-Paula, Daniel S Kerr, Gustavo Scola, et al.
International Psychogeriatrics|May 16, 2007
Mini-mental State Examination performance in mild cognitive impairment subtypesBreno S O Diniz, Monica S Yassuda, Paula V Nunes, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 11, 2012
Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer's diseaseIsis A Zainaghi, Leda L Talib, Breno S Diniz, et al.
Neurobiology of Aging|December 17, 2009
Neurostructural predictors of Alzheimer's disease: a meta-analysis of VBM studiesLuiz K Ferreira, Breno S Diniz, Orestes V Forlenza, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 17, 2013
Low platelet iPLA₂ activity predicts conversion from mild cognitive impairment to Alzheimer's disease: a 4-year follow-up studyWagner F Gattaz, Leda L Talib, Evelin L Schaeffer, et al.
Therapeutic Advances in Drug Safety|August 25, 2015
Anti-dementia medications: current prescriptions in clinical practice and new agents in progressFlorindo Stella, Márcia Radanovic, Paulo Renato Canineu, et al.
European Archives of Psychiatry and Clinical Neuroscience|June 21, 2019
Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot studyAlana C Costa, Helena P G Joaquim, Orestes V Forlenza, et al.
Pageof 14

Showing results (41-50 of 135) with videos related to

Sort By:
Pageof 14
Neuropsychiatric Disease and Treatment|July 18, 2014
Eye movement analysis and cognitive processing: detecting indicators of conversion to Alzheimer's diseaseMarta Lg Freitas Pereira, Marina von Zuben A Camargo, Ivan Aprahamian, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|July 31, 2009
Short cognitive performance test: diagnostic accuracy and education bias in older Brazilian adultsMariana K Flaks, Orestes V Forlenza, Fernanda S Pereira, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|April 14, 2012
A radioenzymatic assay to identify three groups of phospholipase A(2) in plateletsLeda L Talib, Breno S Diniz, Isis A Zainaghi, et al.
Current Alzheimer Research|February 20, 2016
Lithium Distinctly Modulates the Secretion of Pro- and Anti- Inflammatory Interleukins in Co-Cultures of Neurons and Glial Cells at Therapeutic and Sub-Therapeutic ConcentrationsVanessa J De-Paula, Daniel S Kerr, Gustavo Scola, et al.
International Psychogeriatrics|May 16, 2007
Mini-mental State Examination performance in mild cognitive impairment subtypesBreno S O Diniz, Monica S Yassuda, Paula V Nunes, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 11, 2012
Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer's diseaseIsis A Zainaghi, Leda L Talib, Breno S Diniz, et al.
Neurobiology of Aging|December 17, 2009
Neurostructural predictors of Alzheimer's disease: a meta-analysis of VBM studiesLuiz K Ferreira, Breno S Diniz, Orestes V Forlenza, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 17, 2013
Low platelet iPLA₂ activity predicts conversion from mild cognitive impairment to Alzheimer's disease: a 4-year follow-up studyWagner F Gattaz, Leda L Talib, Evelin L Schaeffer, et al.
Therapeutic Advances in Drug Safety|August 25, 2015
Anti-dementia medications: current prescriptions in clinical practice and new agents in progressFlorindo Stella, Márcia Radanovic, Paulo Renato Canineu, et al.
European Archives of Psychiatry and Clinical Neuroscience|June 21, 2019
Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot studyAlana C Costa, Helena P G Joaquim, Orestes V Forlenza, et al.
Pageof 14